309 - Prolongation of Eosinophilic Esophagitis Treatment with Budesonide Orodispersible Tablets for Incomplete Responder is Effective and Safe: Results from a 6-Weeks Open-Label Treatment Phase of the Pivotal Trial EOS-1

Autor:	Jan Tack, Roland Greinwald, Stefan Schubert, Ralph Mueller, Alex Straumann, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Albert J. Bredenoord, Alfredo J. Lucendo, Stephen Attwood, Stefan Brückner, Dirk Hartmann, Christoph Schlag, Javier Molina-Infante, Stephan Miehlke, Constanza Ciriza de los Ríos, Jamal O. Hayat, Alain M. Schoepfer
Rok vydání:	2018
Předmět:	Budesonide medicine.medical_specialty Hepatology business.industry OPEN LABEL TREATMENT Gastroenterology Prolongation medicine.disease Internal medicine Medicine business Eosinophilic esophagitis medicine.drug
Zdroj:	Gastroenterology. 154:S-75
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(18)30704-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ff0cba205efa53eccad95e4b1807a5c1 https://doi.org/10.1016/s0016-5085(18)30704-2 Zobrazit plný text záznamu